XRCC1 Monoclonal Antibody (144) | Invitrogen MA1-12640 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

XRCC1 Monoclonal Antibody (144)

catalog :

MA1-12640

quantity :

100 uL

price :

US 167.00

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

144

reactivity :

human

application :

western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, immunohistochemistry - paraffin section

citations: 6

Reference
Parolini I, Degrassi M, Spadaro F, Caponnetto F, Fecchi K, Mastantuono S, et al. Intraluminal vesicle trafficking is involved in the secretion of base excision repair protein APE1. FEBS J. 2024;291:2849-2875 pubmed publisher
Bahar E, Kim J, Kim H, Yoon H. Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression. Int J Mol Sci. 2020;21: pubmed publisher
Antoniali G, Marcuzzi F, Casarano E, Tell G. Cadmium treatment suppresses DNA polymerase Î´ catalytic subunit gene expression by acting on the p53 and Sp1 regulatory axis. DNA Repair (Amst). 2015;35:90-105 pubmed publisher
Markkanen E, Fischer R, Ledentcova M, Kessler B, Dianov G. Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability. Nucleic Acids Res. 2015;43:3667-79 pubmed publisher
Khoronenkova S, Dianov G. ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc Natl Acad Sci U S A. 2015;112:3997-4002 pubmed publisher
Rybarova S, Vecanova J, Hodorová I, Mihalik J, Cizmáriková M, Mojzis J, et al. Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. Med Sci Monit. 2011;17:BR354-63 pubmed

product information

Product Type :

Antibody

Product Name :

XRCC1 Monoclonal Antibody (144)

Catalog # :

MA1-12640

Quantity :

100 uL

Price :

US 167.00

Clonality :

Monoclonal

Purity :

protein A

Host :

Mouse

Reactivity :

Human

Applications :

Immunocytochemistry: 2 ug/mL, Immunohistochemistry (Paraffin): 1:100-1:400, Immunoprecipitation: 2 ug/mL, Western Blot: 1-2 ug/mL

Species :

Human

Clone :

144

Isotype :

IgG2a, kappa

Storage :

4 C

Description :

XRCC1 (X-ray cross complementing factor-1) is involved in DNA base excision repair. XRCC1 is a 70 kDa protein that has been shown to be physically associated with other DNA repair enzymes, including poly (ADP-ribose) polymerase (PARP), DNA Ligase III and DNA polymerase beta. XRCC1 contains a BRCT domain (for BRCA1 carboxyl terminus) which was originally found in the tumor suppressor protein BRCA1. Recently, the BRCT domain has been shown to mediate the protein-protein interaction of XRCC1 and DNA ligase III-alpha.

Immunogen :

Recombinant human XRCC1 protein

Format :

Liquid

Applications w/Dilutions :

Immunocytochemistry: 2 ug/mL, Immunohistochemistry (Paraffin): 1:100-1:400, Immunoprecipitation: 2 ug/mL, Western Blot: 1-2 ug/mL

Aliases :

DNA repair protein XRCC1; RCC; X-ray repair complementing defective repair in Chinese hamster cells 1; X-ray repair cross complementing 1; x-ray repair cross-complementing group 1 protein; X-ray repair cross-complementing protein 1; XRCC1; Xrcc-1